Clinical Trials Browser

Phase 1/2 × labetuzumab × Breast × Clear all

NCT00041652 2021-08-19

Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer

Phase 1/2 Completed

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms